New implant offers hope for nerve repair after spinal cord injury

A research team at RCSI University of Medicine and Health Sciences has developed a new implant that conveys electrical signals and may have the potential to encourage nerve cell (neuron) repair after spinal cord injury.

Epcoritamab gains positive opinion for lymphoma therapy

AbbVie’s epcoritamab is intended to treat adult patients with relapsed/refractory DLBCL. Credit: AbbVie Inc. AbbVie has received a positive opinion from the Committee for Medicinal

July 24, 2023

Collegium pays $525M to buy ADHD company; FDA delays Syndax decision

Plus, news about Cipher, ParaPRO, Viracta, ReviR Therapeutics and Luye Pharma: Collegium’s $525M acquisition: The pain biotech plans to pay that … Sign up to

July 30, 2024

Bowel Research UK partners with Symplectic Grant Tracker to advance life-changing research

Digital Science, a technology company serving stakeholders across the research ecosystem, is pleased to announce that Bowel Research UK (BRUK) has chosen Symplectic Grant Tracker

July 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.